logo

OPK

OPKO Health·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

OPK fundamentals

OPKO Health (OPK) released its earnings on Oct 29, 2025: revenue was 151.70M (YoY -12.62%), missed estimates; EPS was 0.03 (YoY 0.00%), beat estimates.
Revenue / YoY
151.70M
-12.62%
EPS / YoY
0.03
0.00%
Report date
Oct 29, 2025
OPK Earnings Call Summary for Q3,2025
  • Strategic Divestiture Success: $192.5M from oncology division sale, with $32.5M earn-out potential.
  • 4Kscore Test Growth: 20% Q3 volume increase, poised for accelerated growth with FDA label expansion.
  • Therapeutics Pipeline Expansion: 4 candidates in clinical trials, including new MDX2004 immune rejuvenator.
  • Regeneron Collaboration: $1B+ potential milestone payments for multispecific antibody programs.
  • 2026 Outlook: Diagnostics to reach breakeven in Q4 2025, Pharmaceuticals revenue growth 3-5%.
EPS
Revenue

Revenue & Expenses

OPK has released its 2025 Q3 earnings report, with revenue of 151.67M, reflecting a YoY change of -12.65%, and net profit of 21.63M, showing a YoY change of -13.09%. The Sankey diagram below clearly presents OPK's revenue sources and cost distribution.

Key Indicators

OPKO Health (OPK) key financial stats and ratios, covering profitability, financial health, and leverage.
OPKO Health (OPK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
OPKO Health (OPK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
OPKO Health (OPK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does OPKO Health (OPK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track OPKO Health (OPK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield